切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (05) : 307 -311. doi: 10.3877/cma.j.issn.2095-3232.2014.05.012

所属专题: 文献

基础研究

荧光成像技术活体示踪裸鼠肝细胞癌肺转移
叶志强1, 刘旭辉1, 吴飞龙1, 赵坤2, 潘卫东2,()   
  1. 1. 510630 广州,中山大学附属第三医院急诊科
    2. 510630 广州,中山大学附属第三医院肝胆外科
  • 收稿日期:2014-06-17 出版日期:2014-10-10
  • 通信作者: 潘卫东
  • 基金资助:
    国家自然科学基金(81172783)

Tracking pulmonary metastasis of hepatocellular carcinoma of nude mouse in vivo using fluorescence imaging

Zhiqiang Ye1, Xuhui Liu1, Feilong Wu1, Kun Zhao2, Weidong Pan2,()   

  1. 1. Emergency Department, the Third Afflicted Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2014-06-17 Published:2014-10-10
  • Corresponding author: Weidong Pan
  • About author:
    Corresponding author: Pan Weidong, Email:
引用本文:

叶志强, 刘旭辉, 吴飞龙, 赵坤, 潘卫东. 荧光成像技术活体示踪裸鼠肝细胞癌肺转移[J/OL]. 中华肝脏外科手术学电子杂志, 2014, 03(05): 307-311.

Zhiqiang Ye, Xuhui Liu, Feilong Wu, Kun Zhao, Weidong Pan. Tracking pulmonary metastasis of hepatocellular carcinoma of nude mouse in vivo using fluorescence imaging[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(05): 307-311.

目的

探讨荧光素酶标记肝细胞癌(肝癌)细胞的荧光成像技术在活体示踪裸鼠肝癌肺转移中的价值。

方法

应用低转移潜能HCC97L、高转移潜能HCC97H肝癌细胞建立稳定表达荧光素酶的肝癌细胞株HCC97L-FL、HCC97H-FL。24只裸鼠按随机数字表法随机分为HCC97L-FL组和HCC97H-FL组。分别将5×106个HCC97L-FL和HCC97H-FL细胞加入磷酸盐缓冲液(PBS)50 μl,制成细胞悬液。将细胞悬液注入裸鼠尾静脉,建立荧光素示踪的裸鼠肝癌肺转移模型。观察荧光成像示踪肺转移瘤大体标本及组织标本情况。两组数据比较采用t检验。

结果

荧光检测发现,HCC97L-FL、HCC97H-FL细胞均可发出强烈荧光。建模后2~3周,HCC97H-FL组裸鼠的肺部收集到荧光信号,3~4周荧光强度逐渐增强;HCC97L-FL组裸鼠无可见的肺部荧光信号。建模后4周HCC97H-FL组荧光强度为(1.73 ± 0.16)×104 a.u.,明显高于HCC97L-FL组的(0.03 ±0.01)×104 a.u.(t=23.652, P<0.05)。建模后4周HCC97H-FL组裸鼠肺脏密布大小不等转移瘤病灶,部分较大病灶突出于肺脏表面;HCC97L-FL组中未观察到转移瘤。转移瘤癌细胞核异型性明显,具备肝癌特征。

结论

荧光素酶标记肝癌细胞的荧光成像技术可对裸鼠肝癌肺转移进行活体、动态示踪。该技术为体内肝癌细胞生长、侵袭、转移的研究提供了可靠的量化研究手段。

Objective

To investigate the value of fluorescence imaging of labeling the hepatocellular carcinoma (HCC) cells with luciferase in tracking the pulmonary metastasis of HCC of nude mouse in vivo.

Methods

Low metastatic potential HCC97L and high metastatic potential HCC97H cells were transfected into HCC cell lines HCC97L-FL, HCC97H-FL with stable expression of luciferase. A total of 24 nude mice were randomly divided into HCC97L-FL group and HCC97H-FL group by the random number table method. Cell suspension was prepared by adding HCC97L-FL, HCC97H-FL cells (5×106) into the phosphate buffered saline (PBS, 50 μl) respectively. Cell suspension was injected into the caudal vein of nude mice. The model of tracking pulmonary metastasis of HCC with fluorescein was established. The gross and tissue samples of the pulmonary metastasis tracked by fluorescence imaging were observed. The data between two groups were compared using t test.

Results

Through fluorescence detection, intensive fluorescence could be observed in the HCC97L-FL, HCC97H-FL cells. After 2 to 3 weeks of modeling, fluorescence signal was collected from the nude mice lung in HCC97L-FL group. The fluorescence intensity enhanced gradually in 3-4 week. No fluorescence signal was observed in the nude mice lung in HCC97H-FL group. After 4 weeks of modeling, the fluorescence intensity was (1.73 ± 0.16) ×104 a.u. in HCC97H-FL group, which was significantly higher than that in HCC97L-FL group [(0.03 ±0.01) ×104 a.u.] (t=23.652, P<0.05). The nude mice lung in HCC97H-FL group was densely covered with metastatic tumors of varying sizes after 4 weeks of modeling. Some of the bigger tumors were visible on the lung surface. No metastatic tumor was observed in the HCC97L-FL group. The metastatic tumor was observed with an obvious cell nuclear atypia and characteristic feature of HCC.

Conclusions

Fluorescence imaging of using luciferase to label HCC cells can dynamically track the pulmonary metastasis of HCC of nude mouse . This technique provides a reliable quantitative research method for studying the growth, invasion and metastasis of HCC cells in vivo.

图1 活体荧光成像系统检测四种细胞荧光效果
图2 建模后四周活体荧光成像系统检测HCC97L-FL、HCC97H-FL组裸鼠荧光
图3 活体荧光成像系统检测HCC97L-FL、HCC97H-FL组裸鼠荧光强度的变化
图4 HCC97L-FL、HCC97H-FL组裸鼠肺转移瘤大体标本及组织切片
[1]
吴孟超.肝癌在中国[J/CD].中华肝脏外科手术学电子杂志,2012, 1(1):3-4.
[2]
Ye X, Guo Y, Zhang Q, et al. βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway[J]. PLoS One, 2013, 8(1):e55615.
[3]
黄泽萍,王平,郑荣琴,等.常规超声检查与超声造影对肝脏局灶性病变检出能力的比较[J/CD].中华肝脏外科手术学电子杂志,2013, 2(4):29-33.
[4]
Scaggiante B, Kazemi M, Pozzato G, et al. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials[J]. World J Gastroenterol, 2014, 20(5):1268-1288.
[5]
Zhang Q, Du Y, Xue Z, et al. Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging[J]. PLoS One, 2014, 9(1):e85559.
[6]
Zheng SG, Xu HX, Liu LN. Management of hepatocellular carcinoma: the role of contrast-enhanced ultrasound[J]. World J Radiol, 2014, 6(1):7-14.
[7]
Guo Y, Chen W, Wang W, et al. Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem[J]. ACS Nano, 2012, 6(12):10646-10657.
[8]
Page AJ, Cosgrove DC, Philosophe B, et al. Hepatocellular carcinoma: diagnosis, management, and prognosis[J]. Surg Oncol Clin N Am, 2014, 23(2):289-311.
[9]
Higgins MC, Soulen MC. Combining locoregional therapies in the treatment of hepatocellular carcinoma[J]. Semin Intervent Radiol, 2013, 30(1):74-81.
[10]
Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma[J]. Semin Intervent Radiol, 2013, 30(1):3-11.
[11]
Vitale A, Volk M, Cillo U. Transplant benefit for patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2013, 19(48):9183-9188.
[12]
Liu Y, Zhao YM, Akers W, et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study[J]. Transl Res, 203, 162(5):324-331.
[13]
Shen YC, Lin ZZ, Hsu CH, et al. Clinical trials in hepatocellular carcinoma: an update[J]. Liver Cancer, 2013, 2(3/4):345-364.
[14]
Chao JA, Yoon YJ, Singer RH. Imaging translation in single cells using fluorescent microscopy[J]. Cold Spring Harb Perspect Biol, 2012, 4(11):a012310.
[15]
游敏玲,罗满芳,廖蔚茜,等.柴芪益肝颗粒联合紫杉醇抑制裸鼠肝癌生长的在体成像研究[J].南方医科大学学报,2012, 32(7):1042-1045.
[16]
Gohar AV, Cao R, Jenkins P, et al. Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometry[J].Biomed Opt Express, 2013, 4(8):1390-1400.
[17]
Close D, Xu T, Smartt A, et al. The evolution of the bacterial luciferase gene cassette (lux) as a real-time bioreporter[J]. Sensors, 2012, 12(1):732-752.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[6] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[9] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[12] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[13] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[14] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[15] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?